From a clinical/patient perspective the changing of strategy will be better if it all works out. This is probably what we need to remind ourselves of more often when investing in cancer cures/treatments. Bigger picture
From a strictly SP point of view, the change of strategy and all but starting again absolutely killed any momentum (along with the infighting and revolving door of management etc but that's been done to death). The values being thrown around if the original plan worked were out of this world already, wasn't much need to change there
If this works I'm sure no one will complain but yeah, I don't care if we find a new formulation that cures the common cold and covid for $500 SP; stick to this plan and see it through IMO.
Wouldn't let me reply direct for some reason
RAC Price at posting:
85.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)